PROCEPT BioRobotics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -83.91 M

PROCEPT BioRobotics Corporation Operating Cash Flow is USD -83.91 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -19.60% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • PROCEPT BioRobotics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -104.36 M, a 6.41% change year over year.
  • PROCEPT BioRobotics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -98.08 M, a 62.47% change year over year.
  • PROCEPT BioRobotics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -60.37 M, a 17.07% change year over year.
  • PROCEPT BioRobotics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -51.57 M.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities